|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESPIRATORY |
Departments of
1 Medicine
2 Population Health Sciences
3 Orthopeidcs and Rehabilitation, University of Wisconsin, Madison, WI, USA
4 William S. Middleton Veterans Hospital, Madison, WI 53705, USA
An important determinant of [H+] in the environment of the central chemoreceptors is cerebral blood flow. Accordingly we hypothesized that a reduction of brain perfusion or a reduced cerebrovascular reactivity to CO2 would lead to hyperventilation and an increased ventilatory responsiveness to CO2. We used oral indomethacin to reduce the cerebrovascular reactivity to CO2 and tested the steady-state hypercapnic ventilatory response to CO2 in nine normal awake human subjects under normoxia and hyperoxia (50% O2). Ninety minutes after indomethacin ingestion, cerebral blood flow velocity (CBFV) in the middle cerebral artery decreased to 77 ± 5% of the initial value and the average slope of CBFV response to hypercapnia was reduced to 31% of control in normoxia (1.92 versus 0.59 cm1 s1 mmHg1, P < 0.05) and 37% of control in hyperoxia (1.58 versus 0.59 cm1 s1 mmHg1, P < 0.05). Concomitantly, indomethacin administration also caused 4060% increases in the slope of the mean ventilatory response to CO2 in both normoxia (1.27 ± 0.31 versus 1.76 ± 0.37 l min1 mmHg1, P < 0.05) and hyperoxia (1.08 ± 0.22 versus 1.79 ± 0.37 l min1 mmHg1, P < 0.05). These correlative findings are consistent with the conclusion that cerebrovascular responsiveness to CO2 is an important determinant of eupnoeic ventilation and of hypercapnic ventilatory responsiveness in humans, primarily via its effects at the level of the central chemoreceptors.
(Received 29 March 2006;
accepted after revision 21 August 2006;
first published online 24 August 2006)
Corresponding author A. Xie: Pulmonary Physiology Laboratory, William S. Middleton Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, USA. Email: axie{at}facstaff.wisc.edu
This article has been cited by other articles:
![]() |
S. Ogoh, N. Hayashi, M. Inagaki, P. N. Ainslie, and T. Miyamoto Interaction between the ventilatory and cerebrovascular responses to hypo- and hypercapnia at rest and during exercise J. Physiol., September 1, 2008; 586(17): 4327 - 4338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Fan, J. D. Cotter, R. A. I. Lucas, K. Thomas, L. Wilson, and P. N. Ainslie Human cardiorespiratory and cerebrovascular function during severe passive hyperthermia: effects of mild hypohydration J Appl Physiol, August 1, 2008; 105(2): 433 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Steinback and M. J. Poulin Cardiovascular and cerebrovascular responses to acute isocapnic and poikilocapnic hypoxia in humans J Appl Physiol, February 1, 2008; 104(2): 482 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peebles, L. Celi, K. McGrattan, C. Murrell, K. Thomas, and P. N. Ainslie Human cerebrovascular and ventilatory CO2 reactivity to end-tidal, arterial and internal jugular vein PCO2 J. Physiol., October 1, 2007; 584(1): 347 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duffin Measuring the ventilatory response to hypoxia J. Physiol., October 1, 2007; 584(1): 285 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie, C. Murrell, K. Peebles, M. Swart, M. A. Skinner, M. J. A. Williams, and R. D. Taylor Vascular: Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function Exp Physiol, July 1, 2007; 92(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cummings, M. Swart, and P. N. Ainslie Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2 J Appl Physiol, May 1, 2007; 102(5): 1891 - 1898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |